Browse studies

Find your next paid study

3,218 recruiting studies matching your filters

The SUPRAMAX-study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201)

A greater extent of resection of the contrast-enhancing (CE) tumor part has been associated with improved outcomes in high-grade glioma patients. Recent result…

GlioblastomaHigh-grade GliomaGlioblastoma, IDH-wildtype+9 more

Estimated

~$10 – $1,125

Actual pay is set by the research site.

Jasper GerritsenNCT06118723

Phase 1

Phase 1/2 Study Evaluating Genetically Modified Autologous T Cells Expressing a TCR Recognizing a Cancer/Germline Antigen as Monotherapy or in Combination With Nivolumab in Patients With Recurrent and/or Refractory Solid Tumors

The study's purpose is to establish the safety and tolerability of IMA203/IMA203CD8 products with or without combination with nivolumab in patients with solid …

Refractory CancerRecurrent CancerSolid Tumor, Adult+1 more

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Immatics US, Inc.NCT03686124

Phase 2

Using Placental Pathology to Prevent Recurrent Adverse Pregnancy Outcomes: A Pilot Project (UPPPP Trial)

The goal of this randomized clinical trial is to evaluate if we can use placental pathology in a prior pregnancy which had an adverse outcome, such as early de…

Adverse Pregnancy Outcome

Estimated

~$75 – $3,000

Actual pay is set by the research site.

Endeavor HealthNCT06004674

METRICS Study: Metabolic Evaluation Through Resting Indirect Calorimetry in Bladder Cancer

This study is being done to learn more about energy needs and muscle function during treatment for bladder cancer. These insights can help improve future patie…

Bladder Cancer

Estimated

~$10 – $750

Actual pay is set by the research site.

University of Kansas Medical CenterNCT06721260

Phase 2

A Phase 2 Study of Amplitude-Modulated Radiofrequency Electromagnetic Fields in Metastatic Pancreatic Cancer

The objective of this research is to find out what effects (good and bad), the combination of gemcitabine and nab-paclitaxel therapy (GEM-ABR for the rest of t…

Pancreatic CancerMetastatic Adenocarcinoma

Estimated

~$75 – $2,800

Actual pay is set by the research site.

THERABIONIC INC.NCT05776524

Observational

Evaluation of Pulsed Radiofrequency Ablation of the Superior Hypogastric Plexus for Treatment of Bladder Pain Syndrome: A Case Series

Many women suffer from bladder pain syndrome (BPS). There are many treatments, but there is no one universally effective option. The goal of this clinical tria…

Bladder Pain Syndrome

Estimated

~$10 – $750

Actual pay is set by the research site.

Walter Reed National Military Medical CenterNCT06204874

Observational

Decision Making Tool for Contralateral Prophylactic Mastectomy

This trial studies the acceptability and how well decision making tool works in supporting decision making in contralateral prophylactic mastectomy in patients…

Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8+20 more

Estimated

Targeting Nociceptors in Hidradenitis Suppurativa

This study will build on data from mice and humans implicating TRPV1 nociceptors in the pathogenesis of the type-17 chronic inflammatory skin disease Hidradeni…

Hidradenitis SuppurativaHyperhidrosis

Estimated

~$10 – $750

Actual pay is set by the research site.

University of Massachusetts, WorcesterNCT05403710

Observational

The Impact of Open-label Placebo on Sleep and Pain Modulation

The goal of this free-choice parallel design clinical trial is to examine the potential beneficial effects of using open-label placebo (OLP) in improving chron…

Chronic PainHeadache

Estimated

~$10 – $750

Actual pay is set by the research site.

University of Maryland, BaltimoreNCT06225817

Phase 3

A Phase 3, Randomized Study Evaluating the Efficacy and Safety of TAR-210 Erdafitinib Intravesical Delivery System Versus Single Agent Intravesical Chemotherapy in Participants With Intermediate-risk Non-muscle Invasive Bladder Cancer (IR-NMIBC) and Susceptible FGFR Alterations

The main purpose of this study is to compare the disease-free survival between participants receiving treatment with TAR-210 versus investigator's choice of in…

Non-Muscle Invasive Bladder Neoplasms

Estimated

~$50 – $2,100

Actual pay is set by the research site.

Janssen Research & Development, LLCNCT06319820

A Study to Measure Underlying Coronary Stenosis; a Retrospective, Multi-center Study to Measure Efficacy of ECGio Against Multiple Reference Standards

The study objective is to evaluate the effectiveness of the ECGio algorithm in predicting clinically significant coronary artery disease . ECGio's diagnostic p…

Coronary Artery Disease (CAD)

Estimated

~$10 – $1,050

Actual pay is set by the research site.

Heart Input Output IncNCT07375810

Phase 1

Phase I Study of Autologous T Lymphocytes Expressing GD2-specific Chimeric Antigen and Constitutively Active IL-7 Receptors for the Treatment of Patients With GD2-expressing Brain Tumors (GAIL-B)

In this study, there are two treatment groups called Cohort 1 and Cohort 2. Cohort 1 is for patients with diffuse midline glioma, diffuse intrinsic pontine gli…

Diffuse Intrinsic Pontine GliomaHigh Grade GliomaEmbryonal Tumor+1 more

Estimated

~$150 – $3,000

Actual pay is set by the research site.

Baylor College of MedicineNCT04099797